France D - Search Results

1

Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).

Ettmayer P, France D, Gounarides J, Jarosinski M, Martin MS, Rondeau JM, Sabio M, Topiol S, Weidmann B, Zurini M, Bair KW. Ettmayer P, et al. Among authors: france d. J Med Chem. 1999 Mar 25;42(6):971-80. doi: 10.1021/jm9811007. J Med Chem. 1999. PMID: 10090780

2

A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.

García-Echeverría C, Imbach P, France D, Fürst P, Lang M, Noorani AM, Scholz D, Zimmermann J, Furet P. García-Echeverría C, et al. Among authors: france d. Bioorg Med Chem Lett. 2001 May 21;11(10):1317-9. doi: 10.1016/s0960-894x(01)00205-0. Bioorg Med Chem Lett. 2001. PMID: 11392545

3

Thiourea-based gemfibrozil analogues as HDL-elevating agents.

Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR Jr. Coppola GM, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2439-42. doi: 10.1016/s0960-894x(02)00435-3. Bioorg Med Chem Lett. 2002. PMID: 12161152

4

1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agents.

Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR Jr. Coppola GM, et al. Bioorg Med Chem Lett. 2005 Feb 1;15(3):809-12. doi: 10.1016/j.bmcl.2004.10.094. Bioorg Med Chem Lett. 2005. PMID: 15664862

5

Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents.

Coppola GM, Damon RE, Eskesen JB, France DS, Paterniti JR Jr. Coppola GM, et al. Bioorg Med Chem Lett. 2006 Jan 1;16(1):113-7. doi: 10.1016/j.bmcl.2005.09.034. Epub 2005 Oct 10. Bioorg Med Chem Lett. 2006. PMID: 16216504

6

Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by nonreducing gel electrophoresis.

France DS, Hughes TE, Miserendino R, Spirito JA, Babiak J, Eskesen JB, Tapparelli C, Paterniti JR Jr. France DS, et al. J Lipid Res. 1989 Dec;30(12):1997-2004. J Lipid Res. 1989. PMID: 2516111 Free article.

7

Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis.

Burkey BF, France D, Wang H, Ma X, Brand B, Abuhani C, Diffenderfer MR, Marsh JB, Paterniti JR Jr, Fisher EA. Burkey BF, et al. Among authors: france d. J Lipid Res. 1995 Jul;36(7):1463-73. J Lipid Res. 1995. PMID: 7595070 Free article.

8

High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I.

Swanson ME, Hughes TE, Denny IS, France DS, Paterniti JR Jr, Tapparelli C, Gfeller P, Bürki K. Swanson ME, et al. Among authors: france ds. Transgenic Res. 1992 May;1(3):142-7. doi: 10.1007/BF02528779. Transgenic Res. 1992. PMID: 1301210

9

Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase.

Goldberg IJ, Paterniti JR Jr, France DS, Martinelli G, Cornicelli JA. Goldberg IJ, et al. Among authors: france ds. Biochim Biophys Acta. 1986 Sep 12;878(2):168-76. doi: 10.1016/0005-2760(86)90143-8. Biochim Biophys Acta. 1986. PMID: 3756191 Free article.

10

Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.

Dueland S, France D, Wang SL, Trawick JD, Davis RA. Dueland S, et al. Among authors: france d. J Lipid Res. 1997 Jul;38(7):1445-53. J Lipid Res. 1997. PMID: 9254069 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters